| Similar Articles |
|---|
 |
The Motley Fool
October 7, 2010 |
DRIP Portfolio Candidate: Becton, Dickinson Profit from your fear of needles by adding this stock to your DRIP portfolio.   |
The Motley Fool
October 7, 2010 |
DRIP Portfolio Candidate: Walgreen Why this nationally known drugstore should make it into your DRIP portfolio. |
The Motley Fool
April 27, 2005
Stephen D. Simpson |
Becton, Dickinson's Boring Reliability This broadly diversified medical device company doesn't grow fast, but it is consistent. Investors looking for a stable and dependable company with broad exposure to the medical industry should take a look for themselves at Becton, Dickinson. |
The Motley Fool
July 27, 2007
Brian Orelli |
Stability From a Likely Source Becton Dickinson's earnings are solid. The medical device and lab supply company has reported growth in earnings and increases in margins. |
The Motley Fool
October 13, 2010
Seth Jayson |
From Gross to Net at Becton Dickinson With recent margins exceeding historical averages, medical device company Becton Dickinson looks like it's doing fine. |
The Motley Fool
January 4, 2012 |
A Brief History of Becton, Dickinson's Returns While the past decade has seen valuations contract, the coming decade could see stable, even expanding, valuations. |
The Motley Fool
October 21, 2010
Anand Chokkavelu |
6 Health-Care Stocks Near 52-Week Lows Here are the largest health care equipment and services companies (by market cap) that are hugging 52-week lows: Medtronic... Covidien... Stryker... Becton, Dickinson and Company... McKesson... Cardinal Health... |
The Motley Fool
October 28, 2010
Anand Chokkavelu |
7 Health-Care Stocks Near 52-Week Highs Searching the market's peaks for possibilities. |
Chemistry World
October 7, 2014
Phillip Broadwith |
Becton Dickinson to buy CareFusion for $12bn Medical devices giant Becton Dickinson has agreed to buy automation and infection prevention specialist CareFusion for over $12 billion. |
The Motley Fool
August 11, 2010
Charly Travers |
Insiders Are Buying Quidel. Should You? Does insider buying and a cheap price make for a good buy? |
The Motley Fool
April 18, 2011
Andrew Tonner |
Does Corning Deserve a Spot in Your Portfolio? A quick check of the numbers should help get us started. |
The Motley Fool
January 12, 2004 |
Investing One Share at a Time Buy your favorite company in small amounts -- and keep down commissions -- with dividend reinvestment plans, commonly known as "Drips." |
The Motley Fool
November 3, 2011 |
A Brief History of Walgreen's Returns Walgreen's P/E ratio declined by more than 70% over the past 10 years. That's simply incredible. Every bit of Walgreen's earnings growth has been discounted by the market through lower valuations. |
The Motley Fool
January 26, 2006
Stephen D. Simpson |
Little Bits Add Up at Becton Dickinson Nothing flashy here, but consistent performance has delivered exceptional value for this health care and medical technology company. This stock has been nearly a 46-bagger over the past 20 years. |
The Motley Fool
October 5, 2011
Shubh Datta |
At Walgreen, It's Payback Time Walgreen buys back shares and raises its dividend. |
The Motley Fool
January 18, 2011
Russ Krull |
Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold? |
The Motley Fool
July 6, 2007
Mike Cianciolo |
Walgreen: The New Deal Maker Walgreen announces its latest acquisition as it tries to keep pace with the competition. Investors, take note. |
The Motley Fool
October 20, 2005
Stephen D. Simpson |
Baxter Needs Growth Infusion This is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go. Trading at nearly 20 times forward earnings, it seems like expectations of a growth revival are already in the stock. |
The Motley Fool
August 15, 2005
Bobby Shethia |
Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors. |
The Motley Fool
September 16, 2009
Rob Plaza |
Worried About a Correction? Is the market due for a correction? If you think so, these stocks may help you sleep at night. |
The Motley Fool
December 22, 2011
Seth Jayson |
Walgreen Meets on Revenue, Misses on EPS For the quarter ending Nov. 30, Walgreen met expectations on revenue and missed on earnings per share. |
The Motley Fool
November 11, 2011
Dan Caplinger |
Has Walgreen Become the Perfect Stock? Given that drug retail is a low-margin business, it's improbable that Walgreen will ever reach true perfection. But with some help, improving growth numbers is a goal that could be within reach. |
The Motley Fool
November 5, 2007
Brian Orelli |
Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson. |
The Motley Fool
July 29, 2011
Shubh Datta |
A Drug Retailer for Your Portfolio With a strong balance sheet, Walgreen looks like a good buy. |
The Motley Fool
April 16, 2009
Selena Maranjian |
Meet the Dividend Champions Some dividend-paying companies are more impressive than others. Take a look at: Emerson-Electric... Colgate-Palmolive... Lowe's... Kimberly-Clark... Becton Dickinson... McGraw-Hill... Family Dollar... |
The Motley Fool
August 18, 2010
David Meier |
Corning: Deflation Fighter Corning could be a good candidate to keep you ahead of the game. |
The Motley Fool
February 7, 2008
Brian Orelli |
Invitrogen Integrates After a rough 2006 in which it struggled to integrate its acquisitions, Invitrogen used 2007 to show why it made all of its purchases. |
The Motley Fool
December 26, 2006
Matthew Crews |
Walgreen Represents This drugstore business has proven itself; does its stock match up? |
The Motley Fool
November 30, 2009
Rick Aristotle Munarriz |
4 Dividend Stocks Showing You the Money Companies with growing yields can make you rich in more ways than the obvious: consider Roper, McCormick, Hormel, and Becton Dickinson. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
Riding the Hospira Yo-Yo There's a solid foundation on this roller coaster pharmaceutical and drug delivery company. Maybe Hospira's current valuation doesn't make it a "gem," but that's not really within its control. |
The Motley Fool
June 23, 2006
Rich Smith |
Foolish Forecast: Walgreen The retail pharmacy reports its fiscal third-quarter 2006 earnings on Monday. Investors -- buy, sell or waffle? |
The Motley Fool
September 24, 2008
Selena Maranjian |
Beware of Rapidly Growing Dividends Look closely before you jump into some dividend-paying stocks. They're not always a good thing. |
BusinessWeek
September 25, 2006
Gene G. Marcial |
Green-Lighting Walgreen When the market gets choppy, go for the proven long-haul winners like Walgreen. |
